We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Hydrogel Cultivation Generates Large Populations of Activated T-Cells

By LabMedica International staff writers
Posted on 30 Apr 2019
Print article
Image: T-cells interacting with the transparent gel (Photo courtesy of Hawley Pruitt, Johns Hopkins University).
Image: T-cells interacting with the transparent gel (Photo courtesy of Hawley Pruitt, Johns Hopkins University).
A novel hydrogel-based culture system was used to generate activated immune T-cells that were shown to be able to block growth of melanoma tumors in a mouse model.

Current T-cell therapies require the removal and culture of the cells in order to expand their number by several thousand‐fold. However, these cells often lose the phenotype and cytotoxic functionality for mediating effective therapeutic responses. While the extracellular matrix (ECM) has been used to preserve and augment cell phenotype, it has not been applied to cellular immunotherapies.

Investigators at Johns Hopkins University (Baltimore, MD, USA) extended research into the potential use of ECM by producing a hyaluronic acid (HA)‐based hydrogel that was engineered to present the two stimulatory signals required for T‐cell activation. They called this gel an "artificial T‐cell stimulating matrix (aTM)". The investigators created and tested a range of hydrogels with different tactile properties, from very soft - like a single cell - to hard gels resembling the state within a cell-packed lymph node.

Results published in the April 10, 2019, online edition of the journal Advanced Materials revealed that the combination of the ECM environment and mechanically sensitive T-cell receptor signaling from the aTM resulted in a rapid and robust expansion of rare, antigen‐specific CD8+ T-cells. T-cells cultivated onto a soft hydrogel multiplied from just a few cells to about 150,000 cells within seven days. By contrast, conventional methods to stimulate and expand T-cells were able to generate only about 20,000 cells within the same time period. In addition, more than 80% of T-cells implanted onto the soft surface multiplied themselves, compared with none of the T-cells implanted on the firmest type of hydrogel.

In a mouse melanoma model system, tumors in animals treated with T-cells cultured on hydrogels remained stable in size, and some of the mice survived beyond 40 days. By contrast, tumors in mice injected with T-cells cultured in plastic dishes grew, and none of these mice lived beyond 30 days.

"One of the surprising findings was that T-cells prefer a very soft environment, similar to interactions with individual cells, as opposed to a densely packed tissue," said senior author Dr. Jonathan Schneck, professor of pathology, medicine, and oncology at Johns Hopkins University. "As we perfect the hydrogel and replicate the essential feature of the natural environment, including chemical growth factors that attract cancer-fighting T-cells and other signals, we will ultimately be able to design artificial lymph nodes for regenerative immunology-based therapy."

Related Links:
Johns Hopkins University

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.